Cart
sales@molnova.com
EP1-antagonist-1
CAS No. 851204-35-8
EP1-antagonist-1( EP1 antagonist 1 )
Catalog No. M26017 CAS No. 851204-35-8
EP1-antagonist-1 is an EP1 antagonist (pKi: 7.54; pIC50: 8.5).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 256 | In Stock |
|
| 5MG | 226 | In Stock |
|
| 10MG | 330 | In Stock |
|
| 25MG | 520 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEP1-antagonist-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionEP1-antagonist-1 is an EP1 antagonist (pKi: 7.54; pIC50: 8.5).
-
DescriptionEP1-antagonist-1 is an EP1 antagonist (pKi: 7.54; pIC50: 8.5).
-
In Vitro——
-
In Vivo——
-
SynonymsEP1 antagonist 1
-
PathwayOthers
-
TargetOther Targets
-
RecptorCleavable
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number851204-35-8
-
Formula Weight470.14
-
Molecular FormulaC19H15BrCl2N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1cc(nn1Cc1cc(Br)ccc1OCc1ccc(Cl)cc1Cl)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Staben LR, et al. Stabilizing a Tubulysin Antibody-Drug Conjugate To Enable Activity Against Multidrug-Resistant Tumors. ACS Med Chem Lett. 2017 Sep 5;8(10):1037-1041.
molnova catalog
related products
-
Thalidomide-O-C6-NH2...
Thalidomide-O-C6-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate.
-
Diminazene Aceturate
Diminazene, also known as Diminazine, 4,4’-(Diazoamino)benzamidine, 4,4’-(1-Triazene-1,3-diyl)bis-benzenecarboximidamide, Diminazine aceturate, or Diminazene aceturate, is a trypanocidal agent.
-
Frovocimab
Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody to Subtilisin/Kexin Protein Converting Enzyme Type 9 (PCSK9) that binds to the catalytic domain of PCSK9 and lowers low-density lipoprotein cholesterol (LDL-C) in patients with hypercholesterolemia.Frovocimab is used in the study of hypercholesterolemia.
